Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1373/CLINCHEM.2003.026914PMID 14709652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Two Strategies for Administering Nevirapine to Prevent Perinatal HIV Transmission in High-Prevalence, Resource-Poor Settings

  2003cited by this paper
• Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

  2003cited by this paper
• A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up

  2003cited by this paper
• A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

  2003cited by this paper
• Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA

  2002cited by this paper
• Simultaneous Quantitative Assay of Six HIV Protease Inhibitors, One Metabolite, And Two Non-Nucleoside Reverse Transcriptase Inhibitors in Human Plasma by Isocratic Reversed-Phase Liquid Chromatography

  2002cited by this paper
• Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis

  2002cited by this paper
• Normal ras genes: their onco-suppressor and pro-apoptotic functions (review).

  2002cited by this paper
• Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.

  2002cited by this paper
• Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatography.

  2001cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.

  2001cited by this paper
• Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism.

  2000cited by this paper
• Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study.

  1999cited by this paper
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

  1999cited by this paper
• K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.

  1999cited by this paper
• Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis.

  1999cited by this paper
• Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer.

  1997cited by this paper
• Cell death in colorectal polyps as evaluated by in situ 3‘‐tailing reaction and its relationship to BCL‐2 expression

  1995cited by this paper
• Role of active cell death (apoptosis) in multi-stage carcinogenesis.

  1995cited by this paper
• "Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment."

  1994cited by this paper

• Direct Capture and Amplification of Small Fragmented DNAs Using Nitrogen-Mustard-Coated Microbeads.

  2022cites this paper
• A New Method for Improving Extraction Efficiency and Purity of Urine and Plasma Cell-Free DNA

  2021cites this paper
• Circulating mitochondrial DNA as a biomarker in critically ill patients: A meta-analysis and trial sequential analysis

  2019cites this paper
• Quantification of circulating cell-free DNA (cfDNA) in urine using a newborn piglet model of asphyxia

  2019cites this paper
• Circulating Cell-Free DNA and Cancer Therapy Monitoring: Methods and Potential.

  2019cites this paper
• Quantification of circulating cell-free DNA (cfDNA) in urine using a newborn piglet#_#x00A0;model of asphyxia

  2019cites this paper
• LOH at 6 q and 10 q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival

  2018cites this paper
• Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.

  2018cites this paper
• Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkers

  2016cites this paper
• CNAPS in Therapy Monitoring

  2015cites this paper
• Cell‐Free DNA: An Upcoming Biomarker in Transplantation

  2015cites this paper
• Quantification of concentration and assessment of EGFR mutation in circulating DNA

  2015cites this paper
• Plasma cell-free DNA in diagnostic KRAS mutation testing

  2015cites this paper
• Quantifizierung von zirkulierenden mikroRNAs im Blut von Mammakarzinom-Patientinnen und ihre Evaluierung als neuer Blut-basierter Tumormarker

  2014cites this paper
• Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies

  2014cites this paper
• Liquid biopsy: monitoring cancer-genetics in the blood

  2013cites this paper
• Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma

  2013cites this paper
• Circulating DNA markers of gastro-intestinal cancers

  2012cites this paper
• Prognosis Loss of Heterozygosity at Tumor Suppressor Genes Detectable on FractionatedCirculating Cell-Free TumorDNA as Indicator of Breast Cancer Progression

  2012cites this paper
• Male Microchimerism at High Levels in Peripheral Blood Mononuclear Cells from Women with End Stage Renal Disease before Kidney Transplantation

  2012cites this paper
• Detection of hypermethylated vimentin in urine of patients with colorectal cancer.

  2012cites this paper
• LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival

  2012cites this paper
• Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma

  2012cites this paper
• Imaging , Diagnosis , Prognosis Loss of Heterozygosity at Tumor Suppressor Genes Detectable on FractionatedCirculating Cell-Free TumorDNA as Indicator of Breast Cancer Progression

  2012cites this paper
• Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression

  2012cites this paper
• Circulating DNA and next-generation sequencing.

  2012cites this paper
• Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.

  2011cites this paper
• Circulating tumour markers can define patients with normal colons, benign polyps, and cancers

  2011cites this paper
• A Modified Extraction Method of Circulating Free DNA for Epidermal Growth Factor Receptor Mutation Analysis

  2011cites this paper
• Circulating tumour markers can define patients with normal colons, benign polyps and cancers

  2011cites this paper
• Clinical Relevance of Circulating Nucleic Acids in Blood of Prostate Cancer Patients

  2011influential citation
• K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer.

  2010cites this paper
• Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

  2010cites this paper
• Circulating free tumor DNA and colorectal cancer.

  2010cites this paper
• Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts

  2010cites this paper
• Circulating DNA as a Biomarker for Early Detection of Cancer: A Brief Update with an Emphasis on Lung Cancer~!2010-06-09~!2010-08-03~!2010-09-06~!

  2010cites this paper
• Quantitative Real-time PCR zum spezifischen Nachweis transrenaler DNA des Mycobacterium tuberculosis complex

  2010cites this paper
• Analyse der freien zirkulierenden DNA von Prostatakarzinom-Patienten auf allelische Imbalance

  2009cites this paper
• Comparison of 7 methods for extracting cell-free DNA from serum samples of colorectal cancer patients.

  2009cites this paper
• Effect of acetylcholine receptor source on detection and quantification of anti-acetylcholine receptor-binding antibody.

  2008cites this paper
• Prostate Cancer: Detection of Free Tumor-Specific DNA in Blood and Bone Marrow

  2008cites this paper
• Preferential amplification of apoptotic DNA from plasma: potential for enhancing detection of minor DNA alterations in circulating DNA.

  2008cites this paper
• Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer

  2008cites this paper
• Detection of Mutated K‐ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps

  2008cites this paper
• Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

  2008cites this paper
• Detecting K-ras mutations in stool from fecal occult blood test cards in multiphasic screening for colorectal cancer.

  2007cites this paper
• Origin and prognostic value of circulating KRAS mutations in lung cancer patients.

  2007cites this paper
• Circulating nucleic acids (CNAs) and cancer--a survey.

  2007cites this paper
• CpG islands: their potential as biomarkers for cancer

  2007cites this paper
• Transrenal DNA testing: progress and perspectives

  2006cites this paper
• The stability of herpes simplex virus type I genomes in infected Vero cells undergoing viral induced apoptosis

  2006cites this paper
• Agreement between K-ras sequence variations detected in plasma and tissue DNA in pancreatic and colorectal cancer.

  2006cites this paper
• Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.

  2006cites this paper
• Hypertriglyceridemia: interaction between APOE and APOAV variants.

  2005cites this paper
• Hypertriglyceridemia : Interaction between APOE and APOAV Variants To the

  2005cites this paper
• Detection of a K-ras mutation in urine of patients with colorectal cancer

  2005cites this paper
• Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer.

  2005cites this paper
• Surrogate markers of efficacy for medical treatment of viral hepatitis.

  2004cites this paper
• Transrenal DNA as a Diagnostic Tool: Important Technical Notes

  2004cites this paper